Sun Park - Tenet Healthcare Executive CFO
| THC Stock | USD 141.98 3.66 2.51% |
CFO
Sun Park is Executive CFO of Tenet Healthcare
| Age | 48 |
| Address | 14201 Dallas Parkway, Dallas, TX, United States, 75254 |
| Phone | 469 893 2200 |
| Web | https://www.tenethealth.com |
Tenet Healthcare Management Efficiency
The company has Return on Asset of 0.0699 % which means that on every $100 spent on assets, it made $0.0699 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5956 %, implying that it generated $0.5956 on every 100 dollars invested. Tenet Healthcare's management efficiency ratios could be used to measure how well Tenet Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.04. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 214.4 M, whereas Intangible Assets are forecasted to decline to about 1.3 B.Similar Executives
| Found 11 records | CFO Age | ||
| Michael Malatesta | Select Medical Holdings | 54 | |
| Dawn CPA | Brookdale Senior Living | 50 | |
| David Doherty | Surgery Partners | 52 | |
| Suzanne CPA | The Ensign Group | 50 | |
| Joel Ackerman | DaVita HealthCare Partners | 59 | |
| Jeffrey Knudson | AMN Healthcare Services | 49 | |
| Brian Scott | AMN Healthcare Services | 50 | |
| David CPA | Surgery Partners | 52 | |
| David Duckworth | Acadia Healthcare | 44 | |
| Suzanne Snapper | The Ensign Group | 50 | |
| Carey Hendrickson | US Physicalrapy | 62 | |
Management Performance
| Return On Equity | 0.6 | ||||
| Return On Asset | 0.0699 |
Tenet Healthcare Leadership Team
Elected by the shareholders, the Tenet Healthcare's board of directors comprises two types of representatives: Tenet Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tenet. The board's role is to monitor Tenet Healthcare's management team and ensure that shareholders' interests are well served. Tenet Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tenet Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Johnston, Chief USPI | ||
| Meghan FitzGerald, Independent Director | ||
| Bill Durham, Chief Network | ||
| Christopher Lynch, Independent Director | ||
| Cecil Haney, Independent Director | ||
| Nadja West, Independent Director | ||
| Liz Johnson, Chief Officer | ||
| Richard Fisher, Independent Director | ||
| Paola Arbour, Executive Vice President, Chief Information Officer | ||
| William III, Vice Relations | ||
| Howard Hacker, Executive Vice President, Chief Compliance Officer | ||
| Lloyd Austin, Independent Director | ||
| Richard Mark, Independent Director | ||
| J Kerrey, Lead Independent Director | ||
| Lisa Foo, Executive Vice President - Commercial Operations | ||
| Tammy Romo, Independent Director | ||
| Sun Park, Executive CFO | ||
| Saumya Sutaria, President, Chief Executive Officer, Chief Operating Officer, Director | ||
| Michael Maloney, Executive Development | ||
| James Bierman, Independent Director | ||
| Thomas Arnst, Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary | ||
| Daniel Cancelmi, Chief Financial Officer, Executive Vice President | ||
| Saumya MD, CEO and President | ||
| Sandra Karrmann, Chief Human Resource Officer, Executive Vice President | ||
| Audrey Andrews, Executive Vice President, General Counsel, Corporate Secretary | ||
| Ronald Rittenmeyer, Executive Chairman of the Board, Chief Executive Officer | ||
| Marie Quintana, Executive Vice President - Communications, Chief Marketing Officer | ||
| Jana Durfee, Senior Officer | ||
| Clint Hailey, Chief VP |
Tenet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tenet Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.6 | ||||
| Return On Asset | 0.0699 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 22.28 B | ||||
| Shares Outstanding | 95.1 M | ||||
| Shares Owned By Insiders | 1.16 % | ||||
| Shares Owned By Institutions | 96.73 % | ||||
| Number Of Shares Shorted | 2.08 M | ||||
| Price To Earning | 11.95 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenet Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.215 | Earnings Share 31.58 | Revenue Per Share 213.204 | Quarterly Revenue Growth 0.011 | Return On Assets 0.0699 |
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenet Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.